Literature DB >> 20849872

Induction of lamina propria Th17 cells by intestinal commensal bacteria.

Koji Atarashi1, Takeshi Tanoue, Kenya Honda.   

Abstract

Th17 cells constitute a subset of activated CD4(+) T cells, characterized by their production of interleukin (IL)-17, IL-17F, and IL-22, that play a critical role in host defence against extracellular pathogens. An intriguing feature of these cells is their selective and constitutive presence in the intestinal lamina propria. The development of intestinal Th17 cells is controlled by intestinal commensal bacteria. Recently, segmented filamentous bacterium (SFB) was identified as a specific bacterial taxon that promotes Th17 differentiation in the small intestine of mice. We discuss the recent advances in our understanding of the mechanism of intestinal Th17 synthesis and its potential implications for the treatment of inflammatory bowel diseases.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20849872     DOI: 10.1016/j.vaccine.2010.09.026

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  The tyrosine phosphatase SHP-1 dampens murine Th17 development.

Authors:  Ileana S Mauldin; Kenneth S Tung; Ulrike M Lorenz
Journal:  Blood       Date:  2012-03-20       Impact factor: 22.113

Review 2.  Gut Microbiota and IL-17A: Physiological and Pathological Responses.

Authors:  Banafsheh Douzandeh-Mobarrez; Ashraf Kariminik
Journal:  Probiotics Antimicrob Proteins       Date:  2019-03       Impact factor: 4.609

3.  Interleukin-17/interleukin-17 receptor axis elicits intestinal neutrophil migration, restrains gut dysbiosis and lipopolysaccharide translocation in high-fat diet-induced metabolic syndrome model.

Authors:  Malena M Pérez; Larissa M S Martins; Murilo S Dias; Camila A Pereira; Jefferson A Leite; Enrico C S Gonçalves; Paula Z de Almeida; Emanuelle N de Freitas; Rita C Tostes; Simone G Ramos; Marcel R de Zoete; Bernhard Ryffel; João S Silva; Daniela Carlos
Journal:  Immunology       Date:  2018-12-27       Impact factor: 7.397

4.  The transcription factor E74-like factor 4 suppresses differentiation of proliferating CD4+ T cells to the Th17 lineage.

Authors:  Ping-Hsien Lee; Monica Puppi; Kimberly S Schluns; Li-Yuan Yu-Lee; Chen Dong; H Daniel Lacorazza
Journal:  J Immunol       Date:  2013-11-20       Impact factor: 5.422

5.  Repeated dose (28-day) administration of silver nanoparticles of varied size and coating does not significantly alter the indigenous murine gut microbiome.

Authors:  Laura A Wilding; Christine M Bassis; Kim Walacavage; Sara Hashway; Pascale R Leroueil; Masako Morishita; Andrew D Maynard; Martin A Philbert; Ingrid L Bergin
Journal:  Nanotoxicology       Date:  2015-11-02       Impact factor: 5.913

6.  Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer.

Authors:  Weiguang Chen; Fanlong Liu; Zongxin Ling; Xiaojuan Tong; Charlie Xiang
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

7.  Interleukin-18 Mediates Immune Responses to Campylobacter jejuni Infection in Gnotobiotic Mice.

Authors:  Stefan Bereswill; Marie E Alutis; Ursula Grundmann; André Fischer; Ulf B Göbel; Markus M Heimesaat
Journal:  PLoS One       Date:  2016-06-20       Impact factor: 3.240

8.  Regulation of T helper 17 by bacteria: an approach for the treatment of hepatocellular carcinoma.

Authors:  Cecilia Ying Ju Sung; Nikki Pui-Yue Lee; Hani El-Nezami
Journal:  Int J Hepatol       Date:  2012-12-17

9.  The IL-23/IL-22/IL-18 axis in murine Campylobacter jejuni infection.

Authors:  Markus M Heimesaat; Ursula Grundmann; Marie E Alutis; André Fischer; Ulf B Göbel; Stefan Bereswill
Journal:  Gut Pathog       Date:  2016-07-06       Impact factor: 4.181

Review 10.  Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases.

Authors:  Eddy Owaga; Rong-Hong Hsieh; Beatrice Mugendi; Sakhile Masuku; Chun-Kuang Shih; Jung-Su Chang
Journal:  Int J Mol Sci       Date:  2015-09-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.